Liangliang Ding
16PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Oct 01, 2021
Gliflozins for the prevention of stroke in diabetes and cardiorenal diseases: A meta-analysis of cardiovascular outcome trials.Li-Min Zhao, Jia-Nan Huang, Mei Qiu
|Jul 07, 2021
Comparative Efficacy of Five SGLT2i on Cardiorenal Events: A Network Meta-analysis Based on Ten CVOTs.Mei Qiu, Liang-Liang Ding, Hai-Rong Zhou
|Jun 28, 2021
Sotagliflozin Reduces HF Events in T2DM Regardless of Baseline Characteristics, Including HF, CKD and LVEF.Li-Min Zhao, Liang-Liang Ding, Ze-Lin Zhan
|May 24, 2021
Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials.Dao-Gen Yin, Liang-Liang Ding, Hai-Rong Zhou
|May 04, 2021
Letter to the Editor regarding the article "SGLT2 inhibitors and cardiovascular and renal outcomes: a meta‑analysis and trial sequential analysis".Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan
|Apr 07, 2021
Use of GLP1RAs and occurrence of respiratory disorders: A meta-analysis of large randomized trials of GLP1RAs.Jin-Ping Wei, Chang-Lin Yang, Wen-Hua Leng
Pageof 3
